Clinical Trials Browser

Carcinoma, Hepatocellular × selinexor × Gastrointestinal × Clear all

NCT05093608 2022-10-17

SELINEXOR in Combination w/Bevacizumab and Atezolizumab in Newly Diagnosed Advanced Hepatocellular Carcinoma

Phase 1 Terminated

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms